Contribution and risks of left ventricular endomyocardial biopsy in patients with cardiomyopathies: A retrospective study over a 28-year period

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

BACKGROUND-: Use of left ventricular (LV) endomyocardial biopsy (EMB) to investigate cardiomyopathies is currently discouraged because it is considered riskier than and as contributive as right ventricular (RV) biopsy. The aim of our study is to report our experience with this option and to discuss its advantages and disadvantages. METHODS AND RESULTS-: In our center from 1983 to 2010, 4221 patients underwent diagnostic EMB. In particular, 2396 (56.8%) underwent biventricular EMB, 1153 (27.3%) underwent selective LVEMB, and 672 (15.9%) underwent selective RVEMB. The rate of complications and histological findings were retrospectively analyzed. The periprocedural major complication rate (perforation with or without cardiac tamponade, embolization) was 0.33% for LVEMB and 0.45% for RVEMB, with a significant decrease in the rate of major complications with time (from 1.6% and 1.9% in 1983-1988 to 0% and 0.3% in 2007-2013, respectively; P

Original languageEnglish
Pages (from-to)1531-1541
Number of pages11
JournalCirculation
Volume128
Issue number14
DOIs
Publication statusPublished - Oct 1 2013

Fingerprint

Cardiomyopathies
Retrospective Studies
Biopsy
Cardiac Tamponade

Keywords

  • biopsy
  • cardiomyopathies
  • complications
  • diagnosis
  • myocarditis

ASJC Scopus subject areas

  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

@article{4944a0564872465b808a2f2cc0892935,
title = "Contribution and risks of left ventricular endomyocardial biopsy in patients with cardiomyopathies: A retrospective study over a 28-year period",
abstract = "BACKGROUND-: Use of left ventricular (LV) endomyocardial biopsy (EMB) to investigate cardiomyopathies is currently discouraged because it is considered riskier than and as contributive as right ventricular (RV) biopsy. The aim of our study is to report our experience with this option and to discuss its advantages and disadvantages. METHODS AND RESULTS-: In our center from 1983 to 2010, 4221 patients underwent diagnostic EMB. In particular, 2396 (56.8{\%}) underwent biventricular EMB, 1153 (27.3{\%}) underwent selective LVEMB, and 672 (15.9{\%}) underwent selective RVEMB. The rate of complications and histological findings were retrospectively analyzed. The periprocedural major complication rate (perforation with or without cardiac tamponade, embolization) was 0.33{\%} for LVEMB and 0.45{\%} for RVEMB, with a significant decrease in the rate of major complications with time (from 1.6{\%} and 1.9{\%} in 1983-1988 to 0{\%} and 0.3{\%} in 2007-2013, respectively; P",
keywords = "biopsy, cardiomyopathies, complications, diagnosis, myocarditis",
author = "Cristina Chimenti and Andrea Frustaci",
year = "2013",
month = "10",
day = "1",
doi = "10.1161/CIRCULATIONAHA.13.001414",
language = "English",
volume = "128",
pages = "1531--1541",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "14",

}

TY - JOUR

T1 - Contribution and risks of left ventricular endomyocardial biopsy in patients with cardiomyopathies

T2 - A retrospective study over a 28-year period

AU - Chimenti, Cristina

AU - Frustaci, Andrea

PY - 2013/10/1

Y1 - 2013/10/1

N2 - BACKGROUND-: Use of left ventricular (LV) endomyocardial biopsy (EMB) to investigate cardiomyopathies is currently discouraged because it is considered riskier than and as contributive as right ventricular (RV) biopsy. The aim of our study is to report our experience with this option and to discuss its advantages and disadvantages. METHODS AND RESULTS-: In our center from 1983 to 2010, 4221 patients underwent diagnostic EMB. In particular, 2396 (56.8%) underwent biventricular EMB, 1153 (27.3%) underwent selective LVEMB, and 672 (15.9%) underwent selective RVEMB. The rate of complications and histological findings were retrospectively analyzed. The periprocedural major complication rate (perforation with or without cardiac tamponade, embolization) was 0.33% for LVEMB and 0.45% for RVEMB, with a significant decrease in the rate of major complications with time (from 1.6% and 1.9% in 1983-1988 to 0% and 0.3% in 2007-2013, respectively; P

AB - BACKGROUND-: Use of left ventricular (LV) endomyocardial biopsy (EMB) to investigate cardiomyopathies is currently discouraged because it is considered riskier than and as contributive as right ventricular (RV) biopsy. The aim of our study is to report our experience with this option and to discuss its advantages and disadvantages. METHODS AND RESULTS-: In our center from 1983 to 2010, 4221 patients underwent diagnostic EMB. In particular, 2396 (56.8%) underwent biventricular EMB, 1153 (27.3%) underwent selective LVEMB, and 672 (15.9%) underwent selective RVEMB. The rate of complications and histological findings were retrospectively analyzed. The periprocedural major complication rate (perforation with or without cardiac tamponade, embolization) was 0.33% for LVEMB and 0.45% for RVEMB, with a significant decrease in the rate of major complications with time (from 1.6% and 1.9% in 1983-1988 to 0% and 0.3% in 2007-2013, respectively; P

KW - biopsy

KW - cardiomyopathies

KW - complications

KW - diagnosis

KW - myocarditis

UR - http://www.scopus.com/inward/record.url?scp=84885022083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885022083&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.13.001414

DO - 10.1161/CIRCULATIONAHA.13.001414

M3 - Article

C2 - 24004501

AN - SCOPUS:84885022083

VL - 128

SP - 1531

EP - 1541

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 14

ER -